Published: Nov. 2022

Messenger RNA, the same genetic material that pharmaceutical companies quickly harnessed to develop game-changing Covid-19 vaccines, is opening up a world of possibilities, and arming doctors with new tools to prevent or combat disease.

In this report, STAT, the most authoritative source for reporting on innovations in health care and biotech, delves into the potential of mRNA. In it, you will:

• Find out which 10 companies are at the forefront of mRNA research.
• Have enough background to understand just how transformative mRNA is likely to be.
• And get a sense of how mRNA is powering the next generation of gene-editing technologies, opening the door to new drugs and novel cancer treatments.